Viewing Study NCT03851432


Ignite Creation Date: 2025-12-24 @ 9:28 PM
Ignite Modification Date: 2025-12-31 @ 2:08 AM
Study NCT ID: NCT03851432
Status: UNKNOWN
Last Update Posted: 2020-07-16
First Post: 2019-02-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Janagliflozin Treat Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Metformin
Sponsor: Sihuan Pharmaceutical Holdings Group Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module